New pill shrinks tumors in some patients with hard-to-treat blood cancers
NCT ID NCT04849416
First seen Feb 06, 2026 · Last updated Apr 30, 2026 · Updated 6 times
Summary
This study tested an oral drug called LOXO-305 in 87 Chinese adults with chronic lymphocytic leukemia, small lymphocytic lymphoma, or non-Hodgkin lymphoma whose cancer had returned or not responded to prior treatments. The main goal was to see how many patients had their tumors shrink or disappear. The drug is taken as a pill and is designed to block a protein that helps cancer cells grow. Participation lasted up to four years.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Affiliated Hospital of Hebei University
Baoding, Hebei, 71066, China
-
Beijing Cancer hospital
Beijing, Beijing Municipality, 100142, China
-
Hainan General Hospital
Haikou, Hainan, 570311, China
-
Harbin Medical University Cancer Hospital
Harbin, Heilongjiang, 150081, China
-
Henan Cancer Hospital
Zhengzhou, Henan, 450008, China
-
Hunan Cancer Hospital
Changsha, Hunan, 410013, China
-
Institute of hematology&blood disease hospital
Tianjin, Tianjin Municipality, 300020, China
-
Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School
Nanjing, Jiangsu, 210000, China
-
Shanghai East Hospital
Shanghai, 200120, China
-
Sichuan Cancer Hospital
Chengdu, Sichuan, 610041, China
-
Southern Medical University Nanfang Hospital
Guangzhou, Guangdong, 510515, China
-
Sun Yat-sen University Cancer Center
Guangzhou, Guangdong, 511400, China
-
The First Affiliated Hospital of Henan University of Science &Technology
Luoyang Shi, Henan, 471003, China
-
The First Affiliated Hospital of Soochow University
Suzhou, Jiangsu, 215066, China
-
The First Hospital of Jilin University
Changchun, Jilin, 130021, China
-
Tianjin Medical University Cancer Institute and Hospital
Tianjin, Tianjin Municipality, 300060, China
-
Wannan Medical College Yijishan Hospital
Wuhu, Anhui, 241001, China
-
Xi'an International Medical Center Hospital
Xi'an, Shaanxi, 710126, China
-
Xiangya Hospital Central South University
Changsha, Hunan, 410008, China
-
Xingtai People's Hospital
Xingtai, Hebei, 054031, China
-
Xinjiang Medical University Cancer Hospital - Urumqi
Ürümqi, Xinjiang, 830000, China
-
Zhejiang Cancer Hospital
Hangzhou, Zhejiang, 310022, China
Conditions
Explore the condition pages connected to this study.